TLR9 and neoplasm: Tumor-derived DNA stimulates dendritic cells in a TLR9-dependent manner, causing them to proliferate, take up antigens, mature within the tumor, and subsequently migrate to the draining lymph nodes to prime tumor-specific CTLs [61], indicating an essential role of TLR9 in anti-tumor immunity.